EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$7.86
-0.15 (-1.87%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+552.5% upside
Low Target
$37.24
Average Target
$51.29
High Target
$70.77
Current Price
$7.86
Current
$7.86
$7.86
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Scenario Analysis
Bear Case
$37.24
373.8%
Low target
Base Case
$51.29
+552.5%
Avg target
Bull Case
$70.77
+800.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.31
-15.6% from high
52-Week Low
$3.86
+103.6% from low
Target vs 52W High
$51.29
+450.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |